207 related articles for article (PubMed ID: 37495918)
1. Information Entropy and Its Applications.
Tsui PH
Adv Exp Med Biol; 2023; 1403():153-167. PubMed ID: 37495918
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis.
Chan HJ; Zhou Z; Fang J; Tai DI; Tseng JH; Lai MW; Hsieh BY; Yamaguchi T; Tsui PH
IEEE J Transl Eng Health Med; 2021; 9():1800612. PubMed ID: 34786215
[No Abstract] [Full Text] [Related]
3. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
Khov N; Sharma A; Riley TR
World J Gastroenterol; 2014 Jun; 20(22):6821-5. PubMed ID: 24944472
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Steatosis Assessment with Ultrasound Small-Window Entropy Imaging.
Zhou Z; Tai DI; Wan YL; Tseng JH; Lin YR; Wu S; Yang KC; Liao YY; Yeh CK; Tsui PH
Ultrasound Med Biol; 2018 Jul; 44(7):1327-1340. PubMed ID: 29622501
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome.
Lin YH; Liao YY; Yeh CK; Yang KC; Tsui PH
Entropy (Basel); 2018 Nov; 20(12):. PubMed ID: 33266617
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Ultrasound in Fatty Liver Disease.
Karlas T; Blank V; Böhlig A
Ultraschall Med; 2021 Apr; 42(2):128-153. PubMed ID: 33622003
[TBL] [Abstract][Full Text] [Related]
7. How to Diagnose Nonalcoholic Fatty Liver Disease.
de Alwis NM; Anstee QM; Day CP
Dig Dis; 2016; 34 Suppl 1():19-26. PubMed ID: 27547937
[TBL] [Abstract][Full Text] [Related]
8. Clinical Value of Information Entropy Compared with Deep Learning for Ultrasound Grading of Hepatic Steatosis.
Chen JR; Chao YP; Tsai YW; Chan HJ; Wan YL; Tai DI; Tsui PH
Entropy (Basel); 2020 Sep; 22(9):. PubMed ID: 33286775
[TBL] [Abstract][Full Text] [Related]
9. Radiologic evaluation of nonalcoholic fatty liver disease.
Lee SS; Park SH
World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).
Cannella R; Borhani AA; Tublin M; Behari J; Furlan A
Abdom Radiol (NY); 2019 May; 44(5):1816-1824. PubMed ID: 30788556
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
Kaswala DH; Lai M; Afdhal NH
Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224
[TBL] [Abstract][Full Text] [Related]
12. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
Castera L; Friedrich-Rust M; Loomba R
Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.
Papatheodoridi M; Cholongitas E
Curr Pharm Des; 2018; 24(38):4574-4586. PubMed ID: 30652642
[TBL] [Abstract][Full Text] [Related]
15. Free Triiodothyronine Is Associated With Hepatic Steatosis and Liver Stiffness in Euthyroid Chinese Adults With Non-Alcoholic Fatty Liver Disease.
Guo W; Qin P; Li XN; Wu J; Lu J; Zhu WF; Diao QQ; Xu NZ; Zhang Q
Front Endocrinol (Lausanne); 2021; 12():711956. PubMed ID: 34456869
[TBL] [Abstract][Full Text] [Related]
16. Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.
Ebert T; Linder N; Schaudinn A; Busse H; Berger J; Lichtinghagen R; Keim V; Wiegand J; Karlas T
Endocrine; 2017 Nov; 58(2):246-252. PubMed ID: 28914407
[TBL] [Abstract][Full Text] [Related]
17. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
[TBL] [Abstract][Full Text] [Related]
18. How histopathologic changes in pediatric nonalcoholic fatty liver disease influence in vivo liver stiffness.
Hudert CA; Tzschätzsch H; Rudolph B; Loddenkemper C; Holzhütter HG; Kalveram L; Wiegand S; Braun J; Sack I; Guo J
Acta Biomater; 2021 Mar; 123():178-186. PubMed ID: 33472102
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
Younossi ZM; Loomba R; Anstee QM; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Goodman ZD; Chalasani NP; Kowdley KV; George J; Lindor K
Hepatology; 2018 Jul; 68(1):349-360. PubMed ID: 29222917
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Ultrasound Biomarkers to Assess Nonalcoholic Fatty Liver Disease.
Gao J; Zapata I; Chen J; Erpelding TN; Adamson C; Park D
J Ultrasound Med; 2023 Aug; 42(8):1675-1688. PubMed ID: 36744595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
